Previous Article | Next Article ![]()
Infection and Immunity, September 2000, p. 5344-5353, Vol. 68, No. 9
Molecular Microbiology Unit, Women's and
Children's Hospital, North Adelaide, South Australia 5006, Australia
Received 18 February 2000/Returned for modification 24 March
2000/Accepted 19 May 2000
Shiga toxigenic Escherichia coli (STEC) strains are
important human pathogens which are capable of causing diarrhea,
hemorrhagic colitis, and the potentially fatal hemolytic-uremic
syndrome (HUS). An important virulence trait of certain STEC strains,
such as those belonging to serogroup O157, is the capacity to produce attaching and effacing (A/E) lesions on enterocytes, a property encoded
by the locus for enterocyte effacement (LEE). LEE contains the
eae gene, which encodes intimin, an outer membrane protein which mediates the intimate attachment of bacteria to the host epithelial cell surface, and eae is routinely used as a
marker for LEE-positive STEC strains. However, the O157:H Shiga toxigenic Escherichia
coli (STEC) strains are important human pathogens, causing
diarrhea and hemorrhagic colitis, which can lead to systemic
complications, such as the potentially fatal hemolytic-uremic syndrome
(HUS) (26). Many STEC strains belong to a family of
attaching and effacing (A/E) intestinal pathogens (40). The
prototype for A/E bacteria is the nontoxigenic enteropathogenic E. coli (EPEC), which is a leading cause of infantile
diarrhea in developing countries (14). A/E lesions are
characterized phenotypically by localized destruction of the apical
microvilli of intestinal epithelial cells resulting from rearrangement
of the cytoskeleton and by intimate attachment of bacteria to the enterocyte surface. The genetic determinant is the chromosomally encoded pathogenicity island called the locus of enterocyte effacement (LEE) (36). LEE encodes a type III secretion system
(24) and E. coli secreted proteins (Esp) which
deliver effector molecules to the host cell and disrupt the host
cytoskeleton (27, 32). LEE also carries eae and
tir, which encode intimin and Tir, respectively. Intimin is
an outer membrane protein required for intimate attachment to
epithelial cells (25); Tir is the intimin receptor, which is
produced by the bacteria and then translocated into the host cell
membrane (28).
The genes required for the generation of A/E lesions need to be
coordinately expressed in response to environmental stimuli. Until
recently, however, very little was known about the regulation of LEE in
EPEC and STEC. Previously, the per locus of EPEC was shown
to transcriptionally activate eae of LEE and the
bundle-forming pilus (bfp) operon of the EAF plasmid
(10, 19, 51). However, Per has now been shown to be a global
regulator of LEE, as it induces the production of a novel
transcriptional activator, Ler (LEE-encoded regulator) (38).
The genes of LEE are organized into four polycistronic operons, LEE1
through LEE4 (38). Using lacZ fusions,
per was shown to directly activate only LEE1. LEE1 contains
ler (previously known as orf1) (18,
46), and the product of ler then transcriptionally
activates LEE2, LEE3, and, to a lesser extent, LEE4 (38).
Thus, in EPEC, Per and Ler collectively form a regulatory cascade that
activates the expression of LEE genes. This dual regulatory control is
similar to the regulatory cascade of VirF and VirB that activates the
Shigella flexneri type III secretion system and secreted
molecules (2, 15). EPEC Ler is similar to the salmonella DNA
structural protein and transcriptional regulator, H-NS-like protein
(18). H-NS modulates the expression of many environmentally
regulated genes and is one of the most abundant DNA-binding proteins in
enterobacteria. The mechanism of eae and tir
regulation in A/E bacteria is less clear at this stage. Neither
eae nor tir is contained on the polycistronic operons of LEE described earlier. Per activates the expression of
eae in EPEC, but it appears to activate indirectly or
requires additional factors (19, 38, 51). However, no
per homologue has been detected in STEC (19),
although it is possible that an analogous regulator exists.
The majority of STEC isolates associated with serious human
gastrointestinal infections carry eae, although a number of
cases of severe STEC disease complicated by HUS (including one recent outbreak) have been attributed to eae-lacking STEC strains
(44, 45). In addition, the presence of eae in
STEC strains does not always directly correlate with the ability to
adhere to intestinal epithelial cells in vitro (43).
Moreover, Wieler et al. (56) have reported that not all
eae-positive STEC strains isolated from cattle were capable
of producing A/E lesions in vitro, as judged by the fluorescent actin
staining (FAS) assay. In previous studies we have examined the
adherence properties of STEC strains associated with an outbreak of HUS
caused by contaminated fermented sausage (42). These
included an O111:H However, 95SF2 is able to adhere and produce A/E lesions in a FAS assay
when EDL933 ler is expressed from a multicopy plasmid. While
we show that ler increases the level of intimin in O157 STEC, the inability of 95SF2 to adhere in a FAS assay was shown to be
independent of intimin. Thus, the product of ler appears to
enhance intimin-independent adherence in O157 STEC.
Bacterial strains and cloning vectors.
E. coli cloning
hosts used were DH5 Purification of O157 intimin and preparation of anti-intimin
(
0019-9567/00/$04.00+0
Up-Regulation of Both Intimin and
eae-Independent Adherence of Shiga Toxigenic
Escherichia coli O157 by ler and Phenotypic
Impact of a Naturally Occurring ler Mutation
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
STEC strain 95SF2 carries eae but did not produce A/E
lesions on HEp-2 cells, as judged by a fluorescent actin staining
assay. In this assay, 95SF2 adhered poorly to the HEp-2 cells, and
those that did bind exhibited abnormal cell division. In contrast, the O157:H7 STEC strain EDL933 adhered strongly and produced typical A/E
lesions. We have demonstrated that 95SF2 carries a defective LEE
regulatory gene, ler, with a single base change with
respect to that published for ler of EDL933, resulting in
an Ile57-to-Thr substitution. Ler shows homology to
H-NS-like regulators, which are modulators of transcription, and the
mutation occurs in a domain implicated in oligomerization. 95SF2 was
able to adhere and produce A/E lesions on HEp-2 cells when EDL933
ler was expressed from a multicopy plasmid. Conversely,
introduction of a plasmid carrying 95SF2 ler into EDL933
abolished adherence and capacity to form A/E lesions. Studies with
eae deletion derivatives of 95SF2 and EDL933 demonstrated
that the ler-mediated adherence to HEp-2 cells is largely
independent of intimin. We have also demonstrated that EDL933
ler, but not 95SF2 ler, increases the level of
intimin in O157 STEC.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
strain, 95NR1, and an
O157:H
strain, 95SF2, both of which were eae
positive and exhibited a similar capacity to adhere to Henle 407 cells
in a low-dose 3-h assay (43). In the present study, these
strains were examined for capacity to produce A/E lesions on HEp-2
cells using a 6-h FAS assay. While 95NR1 was shown to be A/E positive,
95SF2 did not adhere in significant numbers and did not produce lesions in this assay. We show here that 95SF2 carries a defective
ler gene with a single base change with respect to that
published previously for ler of the A/E positive O157:H7
STEC strain EDL933 (46).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
(supE44
lacU169 [
80 lacZ
M15] hsdR17 recA1 endA1 gyrA96 thi-1 relA1) and
SM10
pir (thi thr leu tonA lacY supE
recA::RP4-2-Tc::Mu Km). STEC strains 95NR1
(O111:H
) and 95SF2 (O157:H
) were isolated
from the Women's and Children's Hospital, North Adelaide, South
Australia, Australia, as described previously (40). STEC
strain EDL933 (O157:H7) has also been described previously (45). All E. coli strains were grown in
Luria-Bertani (LB) broth (unless otherwise indicated) at 37°C,
supplemented with 50 µg of ampicillin or kanamycin
ml
1, where appropriate. Vectors pGEM-7Zf(+) and
pGEM-Teasy were obtained from Promega Biotech, Madison, Wis. These
vectors are essentially the same, with the exception that pGEM-Teasy
has single 3' T overhangs and exists only in the linear form, and so
pGEM-7Zf(+) was used as a negative control in experiments described
here. Phagemid pBluescript KS was obtained from Stratagene, La Jolla,
Calif. M13 minimal medium was prepared as described by Miller
(39) and supplemented prior to use with MgSO4,
glucose, and thiamine-HCl to final concentrations of 0.2 mg
ml
1, 0.5% (wt/vol), and 50 µg ml
1, respectively.
-O157Int).
Intimin of O157 was purified using the
QIAexpressionist His6 fusion protein system (Qiagen Inc.).
The His6 tag was fused to the N-terminal region of intimin,
removing 40 amino acids of the intimin N terminus to delete any
potential signal sequence that may lead to cleavage of the
His6 tag (19). O157 eae was PCR amplified using oligonucleotides MO7
(5'-GATAGGATCCGAATTCATTTGCAAATGGTG-3') and MO8
(5'-AGCTAAGCTTATTCTACACAAACCGCAT-3'), which
incorporate BamHI and HindIII restriction
sites (underlined), respectively. The PCR product then was digested
with BamHI/HindIII and ligated into the
BamHI and HindIII sites of pQE-31 (Qiagen).
This mix was transformed into E. coli SG 13009(pREP4)
(20), and clones were selected by plating on kanamycin and
ampicillin. pQE-31 carrying eae was designated pJCP716, and
the fusion of the His6 tag to the N terminus was confirmed
by sequencing. For large-scale purification of the
His6-O157 intimin fusion protein, log-phase cultures (0.25 to 1 liter) of SG 13009(pJCP716) in LB broth were induced by the addition of IPTG (isopropyl-
-D-thiogalactopyranoside) (2 mM) and grown for a further 3 h. The cells were harvested by
centrifugation and resuspended in 5 ml of 6 M guanidine-HCl-0.1 M
disodium hydrogen orthophosphate-0.01 M Tris-HCl (pH 8.0) per g (wet
weight) and stirred for 1 h at room temperature. The cell lysate
was then centrifuged (10,000 × g for 25 min at 4°C),
and the supernatant was loaded onto a 4-ml Ni-nitrilotriacetic acid
column preequilibrated with 5 column volumes of buffer A (0.5 M NaCl,
15 mM imidazole) at a rate of 15 ml per h. The column was washed with
10 column volumes of buffer A, 5 column volumes of buffer B (8 M urea,
0.1 M disodium hydrogen orthophosphate, 0.01 M Tris-HCl [pH 8.0]), and 4 column volumes of buffer C (8 M urea, 0.1 M disodium hydrogen orthophosphate, 0.01 M Tris-HCl [pH 6.3], 0.25 M NaCl, 5 mM
imidazole). Intimin was eluted from the column using a 0 to 500 mM
imidazole gradient, and 3-ml fractions were collected and stored at
4°C for analysis by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). After analysis, the appropriate fraction
was dialyzed overnight at 4°C against a decreasing concentration of
urea, with dialysis continuing for a further 4 h in
phosphate-buffered saline (PBS), pH 7.5. Glycerol (50%, vol/vol) was
added to the refolded intimin protein, which was then stored at
15°C.
FAS assay and confocal microscopy.
The FAS assay used was a
modification of that described by Knutton et al. (31) and
was performed in triplicate. HEp-2 cells were cultured in Dulbecco's
modified Eagle's medium (DMEM) buffered with 20 mM HEPES supplemented
with 10% fetal bovine serum, 100 U of penicillin ml
1,
100 µg of streptomycin ml
1, and 2 mM
L-glutamine. The HEp-2 cells were then used to seed 1.0-cm-diameter coverslips in 24-well trays and were incubated until
the monolayer was semiconfluent. Monolayers were washed to remove all
antibiotics and were infected with the various strains diluted in DMEM
to a density of 2 × 105 CFU ml
1. After
3 h at 37°C, the cells were washed three times with Dulbecco's PBS and fresh medium was added. The cells were incubated for an additional 3 h at 37°C and washed three times with Dulbecco's PBS and then fixed in PBS-3.7% formaldehyde. The cells were
permeabilized by treatment with 0.1% Triton X-100 in PBS for 2 min,
washed with PBS, and stained with rabbit antiserum specific for the
respective O-antigen type (Oxoid) (diluted 1:100) and incubated at
37°C for 1 h. The coverslips were washed and incubated at 37°C
for 1 h with a combination of goat anti-rabbit immunoglobulin
G-Texas Red conjugate (diluted 1:100; Molecular Probe [Quantum
Scientific]) and phalloidin-fluorescein isothiocyanate (diluted 1:200;
Sigma Chemical Co.). The coverslips were mounted on glass slides with Moviol containing 2% (vol/vol) antibleach (Sigma) and sealed with clear nail polish. The cells were examined with a Bio-Rad MRC600 confocal microscope with a krypton-argon laser. Confocal images were
processed using Confocal assist software.
Construction of
eae derivatives of 95SF2 and
EDL933.
Two fragments flanking eae were generated by
two separate PCRs using chromosomal DNA from either 95SF2 or EDL933 as
template. Fragment 1 was 1.87 kb long and was generated using
oligonucleotides 3005 (5'-CTTCAGATATCACGGAAGC-3')
and 3006 (5'-CTGAAGCTTGTGCCGGGTCCGGGT-3'), which incorporate EcoRV and HindIII
restriction sites (underlined), respectively. Fragment 2 was 2.0 kb
long and was generated using oligonucleotides 3007 (5'-GTCAAGCTTCCTGGGGTTAATGTT-3') and 3008 (5'-TCACCCGGGCATGTTGCCAAACATC-3'), which
incorporate HindIII and SmaI restriction
sites (underlined), respectively. Fragment 1 was digested with
EcoRV/HindIII, and fragment 2 was digested
with HindIII/SmaI. These two fragments were
then coligated into the SmaI site pCVD442 (15).
The ligation of these two fragments at the HindIII site
generates an in-frame deletion of O157 eae, such that 2,716 nucleotides (nt) are removed from the open reading frame, fusing the
DNA encoding the 12 N-terminal amino acids of intimin with that
encoding 17 amino acids of the C terminus. The resultant construct,
pJCP714, was electroporated into SM10
pir, and transformants were
selected with ampicillin. pJCP714 was then conjugated from SM10
pir
into STEC O157. Overnight cultures of donor and recipient strains were
mixed at a ratio of 1:10, and the cells were pelleted by gentle
centrifugation. The pellet was gently resuspended in 200 µl of broth
and spread onto a cellulose acetate membrane filter (0.45-µm pore
size; type HA; Millipore Corp.) on LB agar and incubated for 3 h
at 37°C. The cells were resuspended in 10 ml of saline, and aliquots
were plated onto M13 minimal agar plates (which select for the STEC
recipient strain). The mutant construction strategy is based on that
described by Donnenberg and Kaper (12) but with some
variations. An overnight culture of an exconjugate was plated onto LB
agar (supplemented with 6% sucrose, but without NaCl) and incubated
overnight at 30°C. Ampicillin-sensitive colonies were selected and
screened by PCR.
eae O157 mutants produced a 0.15-kb PCR
product using oligonucleotides eaeF (5'-CTCATCTAACTCATTGTGGG-3')
and eaeR (5'-AAAATATAATATATTTTTAGCCGG-3'). The
in-frame deletion was confirmed by DNA sequencing.
Construction of plasmid-borne ler.
The ler
genes were PCR amplified from EDL933 and 95SF2 chromosomal DNA using
oligonucleotides M31 (5'-CCTCCAGCTCAGTTATCGTT-3') and M32
(5'-ATAACATTCCGGGTTGGTGA-3'). The 2.4-kb PCR products were
ligated to pGEM-Teasy, transformed into DH5
, and selected using
ampicillin. The constructs generated from EDL933 and 95SF2 were
designated pJCP710 and pJCP711, respectively. The EcoRI
fragment of pJCP710 was isolated and ligated into the EcoRI
site of pBluescript KS to generate pJCP712. The EcoRI sites
of pJCP710 lie 893 bp upstream of the start codon of ler and
downstream in the vector polylinker. pJCP713 was generated as described
for pJCP710, except oligonucleotide M35
(5'-TTTGATGAAATAGATGTGTCC-3') was used instead of M32.
Detection of intimin by Western immunoblotting.
Cultures of
bacteria were grown to an A600 of 0.6 to 0.8, and bacterial cultures were adjusted to comparable optical densities prior to gel loading. Whole-cell lysates were prepared by
centrifugation of 1 ml of the culture and resuspending in 100 µl of
SDS sample buffer. Protein samples were resolved by SDS-PAGE
(34), and the proteins were transferred to nitrocellulose
for Western blot analysis as described elsewhere (41).
Filters were probed with
-O157Int antiserum obtained as described
above (diluted 1:2,000), followed by goat anti-mouse immunoglobulin G
conjugated to alkaline phosphatase as described previously
(41).
| |
RESULTS |
|---|
|
|
|---|
A/E adherence phenotype and intimin induction in
eae-positive STEC strains.
Initial experiments
compared the capacities of the eae-positive STEC strains
95SF2, 95NR1, and EDL933 to produce A/E lesions on HEp-2 cells, using
the FAS assay, as described in Materials and Methods. Both 95NR1 and
EDL933 produced typical A/E lesions, but none were observed for cells
infected with 95SF2. Moreover, in spite of the previously observed
capacity of 95SF2 to adhere to Henle 407 cells, very few adherent
bacteria were observed on the HEp-2 cell surface, and those that did
adhere exhibited an abnormal, filamentous phenotype (result not shown).
We then examined the possibility that the failure of 95SF2 to adhere to
cultured HEp-2 cells in the FAS assay is related to the level of
intimin produced by the bacteria. In EPEC, intimin is known to be
induced during log-phase growth, and the level increases when cells are grown in tissue culture medium such as DMEM (30). Therefore, to ensure maximal expression of intimin in the STEC strains under study, cells were grown to mid-log phase in either LB broth or DMEM.
Cell lysates were then subjected to SDS-PAGE and Western immunoblot
analysis using mouse antiserum raised against intimin of STEC 95SF2
(
-O157Int). The deduced amino acid sequence of intimin of 95SF2 is
99.9% identical to that of EDL933, while intimin of 95NR1 exhibits
88.6% identity (55). LB culture lysates of all three STEC
strains contained similar levels of an immunoreactive species of the
expected size (Fig. 1, lanes 1, 5, and
9). Interestingly, DMEM culture lysates of 95NR1 and EDL933 contained
significantly increased levels of the immunoreactive species relative
to the respective LB culture lysates, and there was evidence of
proteolytic degradation (Fig. 1, lanes 3 and 11). However, no such
increase in the level of intimin expression was observed in the DMEM
culture lysate of 95SF2 relative to the LB culture lysate (Fig. 1, lane 7). The absolute specificity of the antiserum for intimin was confirmed
by the absence of immunoreactive species in either LB or DMEM culture
lysates of derivatives of each of the STEC strains carrying
eae in-frame deletion mutations (constructed as described in
Materials and Methods) (Fig. 1, lanes 2, 4, 6, 8, 10, and 12). Thus,
although 95SF2 does produce baseline levels of intimin, it is unable to
up-regulate expression when grown in DMEM.
|
STEC
indistinguishable from 95NR1 (42), raising the possibility of in trans complementation in vivo. HEp-2 cells were
therefore coinfected with both 95SF2 and 95NR1 and examined by FAS
assay. The coinfection was performed in duplicate, and the fixed cells were also incubated with either anti-O111 or anti-O157 serum, which was
then detected by a second antibody conjugated to Texas Red, in order to
distinguish between the two STEC strains. 95NR1 cells produced a
positive FAS response, but 95SF2 was still unable to adhere
significantly and did not produce A/E lesions (result not shown). Thus,
coincubation of 95NR1 with 95SF2 was unable to complement the defect in
95SF2 in trans.
Sequence analysis of 95SF2 ler.
In view of the
possibility that STEC 95SF2 has a regulatory defect, we examined the
ler gene of this strain. A 2.4-kb fragment containing
ler and 1.8 kb of noncoding 5' flanking DNA from 95SF2 was
amplified by PCR and cloned into pGEM-Teasy (generating plasmid pJCP711) (Fig. 2). Comparison of the DNA
sequence of the 2.4-kb insert of pJCP711 with that for the homologous
region of EDL933 (46) revealed two base changes. One of
these (C1593 to T) lies 395 nt upstream of the ATG start
codon of ler. The other (T2157 to C) is 170 nt
downstream of the initiation codon and results in an
Ile57-to-Thr substitution. The positions of the mutations within pJCP711 are shown in Fig. 2. The deduced amino acid sequence of
95SF2 ler was 98% identical to Ler (Orf1) of EPEC
(18), and 48 and 47% identical to the BpH3 proteins from
Bordetella bronchiseptica (6) and B. pertussis (21), respectively. 95SF2 Ler also shows similarity with H-NS of Erwinia chrysanthemi (50% identity)
(GenBank accession number CAA61611), and the H-NS-like StpA DNA-binding proteins of E. coli (48% identity) (59) and
Salmonella enterica serovar Typhimurium (46% identity)
(GenBank accession number O33800). It has recently been shown that
despite low sequence homology, BpH3, StpA, and the
trans-activator protein HvrA of Rhodobacter capsulatus (9) are structurally and functionally
related to H-NS proteins and therefore all belong to the H-NS family
(6). The sequence alignment of 95SF2 Ler with Ler of EDL933
and EPEC and the BpH3 proteins of Bordetella show that the
Ile57 residue is conserved in all these H-NS-like proteins
except for 95SF2 Ler (Fig. 3).
Ile57 is also conserved in StpA of E. coli and
Salmonella and H-NS of E. chrysanthemi (data not
shown).
|
|
Phenotypic characterization of O157 STEC strains 95SF2 and EDL933
carrying various ler constructs.
To examine the
possibility that the nucleotide differences in the ler
region described above account for the abnormal phenotype of 95SF2 in
the FAS assay, the analogous ler region from EDL933 was also
cloned into pGEM-Teasy, generating pJCP710. Two smaller clones
(designated pJCP712 and pJCP713) containing EDL933 ler plus
0.8 and 0.1 kb of 5' flanking DNA, respectively, were also constructed
(Fig. 2). The various ler-containing constructs were electroporated into 95SF2 and EDL933, and the capacities of the transformants to adhere to and produce A/E lesions on HEp-2 cells were
assessed. The impact of expression of the various ler
constructs in the otherwise isogenic eae deletion
derivatives of 95SF2 and EDL933 (designated 95SF2
eae and
EDL933
eae) was also examined. The growth rate of
bacterial cultures harboring the various ler constructs was
measured and was comparable to the growth rate of wild-type
strains (data not shown). Confocal micrographs of HEp-2 cells infected
with the various STEC constructs after FAS assay are shown in
Fig. 4.
|
eae derivative
did not bind to the HEp-2 cells in significant numbers (approximately one to five bacteria per HEp-2 cell), and the majority of bacteria that
did bind had divided incompletely, producing the filamentous phenotype
referred to earlier (Fig. 4A and B, respectively). However, 95SF2
(pJCP710) (carrying EDL933 ler) adhered to HEp-2 cells and produced A/E lesions, characterized by an intense region of polymerized actin (green fluorescence) corresponding in both size and position with
adherent bacteria (red fluorescence) (Fig. 4I). It should be noted,
however, that not all adherent bacteria produced A/E lesions.
Interestingly, 95SF2
eae(pJCP710) was also able to adhere to HEp-2 (Fig. 4J), which suggests that the pJCP710-mediated adherence does not depend on intimin. However, the numbers of adhered bacteria were slightly less than that of 95SF2(pJCP710), and bacteria often bound to the edges of the HEp-2 cells (Fig. 4J). The phenotypes of
95SF2(pJCP712) and 95SF2
eae(pJCP712) were the same as
those seen in Fig. 4I and 4J, respectively (result not shown).
Interestingly, however, the capacity of 95SF2 to adhere and produce A/E
lesions on HEp-2 cells in the FAS assay was greatly enhanced by pJCP713
(Fig. 4M). This plasmid differs from the other EDL933 ler
constructs in the length of the 5' region (100 bp, compared with 1.8 and 0.8 kb for pJCP710 and pJCP712, respectively). The image shown in
Fig. 4M represents only one focal plane. However, examination of
higher and lower focal planes indicated the presence of adherent
bacteria, as well as associated A/E lesions, over almost the entire
surface of the HEp-2 cells. This up-regulation of adherence was also
intimin independent, as seen with 95SF2
eae(pJCP713) in
Fig. 4N. The fact that pJCP713 can complement the abnormal phenotype of
95SF2 indicates that the amino acid substitution in 95SF2 Ler,
rather than the nucleotide substitution 395 nt upstream of
ler, is entirely reasonable for the observed effects. 95SF2 containing either cloning vectors pBluescript KS or pGEM-7Zf(+) have
the same adherence (FAS) phenotype as that of the wild-type strain
(data not shown). The expression of 95SF2 ler from the multicopy plasmid pJCP711 in both 95SF2 and its
eae
derivative did not induce adherence to the HEp-2 cells (Fig. 4E and
4F). While the bacteria shown in these two panels appear normal, others were present in the filamentous form seen in Fig. 4A and B (result not shown).
EDL933 produces A/E lesions, as judged by a positive FAS assay
(Fig. 4C). Overall adherence was reduced in EDL933
eae,
and as expected, there were no A/E lesions (Fig. 4D). A similar
finding has been reported by McKee et al. (37). The
phenotypes of EDL933 and EDL933
eae carrying either
pBluescript KS or pGEM-7Zf(+) were the same as the parental strains
(data not shown). EDL933(pJCP710) showed a slight increase in
adherence and ability to produce A/E lesions, over and above that
of the wild-type strain (Fig. 4K). EDL933
eae(pJCP710)
also showed increased adherence (Fig. 4L) compared to
EDL933
eae. pJCP712 did not significantly enhance the
adherence of EDL933 or its
eae derivative in the FAS
assay (data not shown). However, the ability of EDL933 to adhere to HEp-2 cells and produce A/E lesions was greatly enhanced by the presence of pJCP713 (Fig. 4O), an effect similar to that seen with
95SF2(pJCP713) (Fig. 4M). Again, the enhancement of adherence was not
intimin dependent, as shown for EDL933
eae(pJCP713) in Fig. 4P.
Surprisingly, EDL933(pJCP711) (expressing 95SF2 ler)
exhibited a 95SF2-like phenotype in the FAS assay. The number of
EDL933(pJCP711) cells adhering to HEp-2 was greatly reduced, and these
displayed the filamentous phenotype (Fig. 4G) normally associated with
95SF2; A/E lesions were also not observed. The phenotype of
EDL933
eae(pJCP711) was similar to that of EDL933(pJCP711)
(Fig. 4H).
The presence of ler increases the level of intimin in
STEC O157.
The ler gene clearly plays a significant
role in LEE-associated functions, as shown here and elsewhere
(36). However, it is not yet known whether
ler affects the levels of intimin in O157 STEC. To determine
this, O157 strains 95SF2 and EDL933 carrying ler-bearing
plasmids were subjected to Western immunoblot analysis. Whole-cell
lysates of log-phase cultures were subjected to SDS-PAGE and probed
with
-O157Int. Figure 5A clearly shows
that the levels of intimin in 95SF2 and EDL933 increase when these
strains carry pJCP710 (which carries the gene encoding EDL933 Ler), but
this was not seen in cells carrying pJCP711 (the otherwise identical construct which carries the gene encoding 95SF2 Ler).
|
eae derivative but
did not enhance the adherence of EDL933 or its
eae
derivative). H-NS consensus sites (5'-TNTNAN-3')
(48) are located upstream of eae (data not
shown); however, it is not known whether these sites are involved with
Ler binding. It should also be noted that H-NS binds to AT-rich DNA,
which is usually naturally curved (35), and both the region
5' to eae and the coding region itself are unusually AT rich
for E. coli DNA (63 and 65% A+T, respectively). Several
copies of the consensus sequence are also located upstream of the
enterohemorrhagic E. coli espA gene (5).
| |
DISCUSSION |
|---|
|
|
|---|
The capacity to cause A/E lesions on intestinal epithelial cells is considered to be an important accessory factor, if not an essential virulence determinant, of STEC strains such as those belonging to serogroup O157 (40). Production of intimin, encoded by eae, has been a commonly used marker for this capacity. However, generation of A/E lesions requires coordinate regulation of expression of eae and many other LEE-encoded genes. Lesion formation is also believed to be preceded by adherence of the bacterium to the epithelial cell surface. Studies of EPEC strains have demonstrated that the LEE-encoded regulatory protein Ler acts as a direct transcriptional activator of several polycistronic LEE operons (38). However, the role of ler in STEC has yet to be fully defined, and furthermore, up-regulation of eae itself has not been previously demonstrated in STEC.
In the present study, we have examined the molecular basis for
the failure of an eae-positive O157 STEC strain (95SF2),
isolated from a patient with HUS, to generate A/E lesions on HEp-2
cells in vitro. This strain also exhibited a diminished capacity to adhere to the surface of these cells and displayed an abnormal filamentous phenotype suggestive of a defect in cell division. 95SF2
was capable of producing levels of intimin similar to those of other
STEC strains such as 95NR1 and EDL933 (which can form A/E lesions) when
grown in LB broth. However, unlike these two strains, 95SF2 did not
exhibit increased intimin production when grown in DMEM, implying a
defect in a regulatory pathway. Cloning and sequence analysis of 95SF2
ler revealed the presence of a single nucleotide difference
with respect to EDL933 ler, resulting in an
Ile57-to-Thr substitution. Introduction of EDL933
ler on the multicopy plasmid pJCP710, pJCP712, or pJCP713
into 95SF2 conferred normal cell morphology, increased intimin levels,
and the capacity to produce A/E lesions. It also resulted in massively increased adherence of bacteria to the HEp-2 cell surface in the deletion derivative 95SF2
eae. Introduction of EDL933
ler on a multicopy plasmid also further enhanced adherence
and the A/E capacity of EDL933, as well as adherence in the deletion
derivative EDL933
eae. Conversely, introduction of 95SF2
ler on pJCP711 into 95SF2 did not correct any of the
phenotypic defects of this strain. Interestingly, introduction of this
95SF2 ler plasmid into EDL933 conferred a phenotype
indistinguishable from that of 95SF2, i.e., abnormal filamentous cell
morphology, inability to increase intimin levels, lack of adherence to
HEp-2 cells, and failure to form A/E lesions.
The data presented here and elsewhere support the proposal that Ler of STEC and EPEC belong to the H-NS family of global regulators (16, 38). Ler shows similarities with the H-NS-like proteins BpH3 of B. bronchiseptica (6) and B. pertussis (21) and the StpA proteins of E. coli (59) and S. enterica serovar Typhimurium (GenBank accession number 033800). While members within the enterobacterial H-NS group exhibit strong amino acid conservation (2), H-NS-like proteins (BpH3, StpA, and HvrA) exhibit only weak amino acid conservation with H-NS (6). However, despite the low level conservation of H-NS with that of H-NS-like proteins, they are functionally and structurally related DNA-binding proteins (6). H-NS can be divided into two functional domains: an N-terminal oligomerization domain and a C-terminal DNA-binding domain. The requirement of the N-terminal domain for oligomerization has been demonstrated both in vivo and in vitro (54, 57). The mutation in 95SF2 Ler lies within the N-terminal domain, and while there is virtually no homology between the N-terminal domain of Ler and that of H-NS, we suggest that there may be functional conservation, based on the similarities of Ler with BpH3. Despite the low amino acid conservation of the N-terminal domain of BpH3 compared with H-NS, the N-terminal domain of BpH3 can functionally complement the N-terminal domain of H-NS (6). In addition, the N-terminal domains of BpH3 and H-NS appear to be structurally conserved, and these domains can be cross-linked to form dimers in vitro (6). It is therefore likely that the mutation in 95SF2 lies within an oligomerization domain that is required for the proper functioning of Ler.
Clearly, studies here show the plasmid-borne allele of ler is dominant to the chromosomal allele, such that plasmid-borne ler determines whether the cell exhibits a Ler-negative or Ler-positive phenotype. This suggests that the level of protein expression determines the phenotype and that Ler encoded by a gene carried by the plasmid is capable of competing with and/or displacing the endogenous Ler. Thus, while the defective 95SF2 Ler may be able to bind DNA, it may be unable to function due the inability to oligomerize. Functional and nonfunctional Ler would therefore compete for the DNA-binding site. Interestingly, Ler also appears to be involved in cell division, thereby influencing gene expression outside of LEE. This is not entirely surprising, as H-NS proteins are known to modulate the expression of a large number of unrelated genes in enterobacteria, which is reflected by the pleiotropic phenotypes displayed by hns mutants (4, 7, 58).
Studies here show that the overexpression of ler in
O157 STEC increases the levels of intimin. Generally, the
best-characterized H-NS-regulated genes are negatively regulated by
H-NS. However, two-dimensional protein analysis has suggested that
there are also many uncharacterized genes which are positively
regulated by H-NS (1, 8). Potential H-NS consensus binding
sites were located upstream of eae, and these binding sites
overlap the predicted
10 and
35 promoter elements. In other
instances where the binding site overlaps the promoter, H-NS represses
the expression of the gene, presumably by interfering with the binding
of the RNA polymerase to the promoter (35, 52, 53).
Therefore, the mechanism by which intimin is regulated by Ler is
unclear at this stage. Further experiments are needed to establish
whether Ler transcriptionally regulates intimin, or alternatively,
whether Ler represses the expression of a gene whose product normally
degrades intimin.
The region upstream of ler may have a role in the expression of ler itself. Both pJCP710 and pJCP713 carry EDL933 ler but vary in the length of the upstream region (approximately 2.0 kb and 100 bp, respectively). However, pJCP713 produced the greatest enhancement of adherence and A/E lesion formation when expressed in either EDL933 or 95SF2. It is possible that the region upstream of ler contains a negative regulatory element, such that deletion of this region allows greater expression of ler from pJCP713.
While there is a substantial body of evidence that intimin is
essential for the intimate attachment of bacteria to epithelial cells
at the site of A/E lesions, it is not clear whether intimin is involved
in the initial adherence which is believed to precede these events
(13). The findings of the present study using otherwise isogenic eae deletion derivatives of 95SF2 and EDL933
unequivocally demonstrate that O157 STEC can adhere efficiently to
HEp-2 cells in the absence of intimin and that this is regulated by
ler. Ebel et al. (17) have recently shown that
the initial binding of STEC to host cells is mediated by filamentous
structures, of which EspA is a major component. During an STEC
infection, these EspA structures are found predominantly on bacteria
that have not yet induced the formation of A/E lesions, and a deletion
mutant of espA in an O26:H
STEC strain almost
completely abolished adherence to HeLa cells and ability to induce
actin rearrangements (17). EspD is essential for the
formation of these EspA filaments, and consequently an STEC
espD mutant also exhibits impaired attachment to HeLa cells (33). EspA filamentous structures are found on the surface
of both EPEC and STEC and are required for the translocation of EspB and Tir into epithelial cells and for the activation of epithelial signal transduction (29, 32, 50). espA is
contained within the polycistronic operon LEE4 of EPEC,
which is modestly up-regulated by ler (38). It is
therefore conceivable that the expression of ler from a
multicopy plasmid in STEC up-regulates one or more of the Esp
molecules, resulting in the up-regulation of intimin-independent adherence. It has been proposed that while EspA appendages mediate the
initial interaction of STEC with the host cell, this is later replaced
by the intimate attachment mediated by intimin (17). It
should be noted, however, that in EPEC the deletion of espA does not eliminate the ability to adhere to host cells, but A/E lesion
formation is abolished (29). We cannot rule out the
possibility that ler is up-regulating an alternate adherence
factor that is not encoded by the LEE locus.
We have demonstrated that in STEC, ler plays a crucial role in both the above processes, as well as impacting on gross cell morphology. However, the fact that 95SF2 (in which ler is clearly defective) was one of two STEC strains isolated from a patient with severe HUS and the frequent occurrence of cases of serious gastrointestinal disease and HUS caused by LEE-negative STEC indicate that the precise role and contribution of ler and other LEE genes in the pathogenesis of human disease remain to be elucidated.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Matthew Woodrow for assistance with raising antisera and to Luisa van den Bosch for helpful advice with microscopy.
This work was supported by a grant from the National Health and Medical Research Council of Australia.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Molecular Microbiology Unit, Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia. Phone: 61-8-8204 6302. Fax: 61-8-8204 6051.E-mailpatonj{at}wch.sa.gov.au.
Editor: A. D. O'Brien
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Abaibou, H.,
J. Pommier,
S. Benoit,
G. Giordano, and M. A. Mandrand-Berthelot.
1995.
Expression and characterization of the Escherichia coli fdo locus and a possible physiological role for aerobic formate dehydrogenase.
J. Bacteriol.
177:7141-7149 |
| 2. | Adler, B., C. Sasakawa, T. Tobe, K. Makino, K. Komatsu, and M. Yoshikawa. 1989. A dual transcriptional activation system for the 230 kb plasmid genes coding for virulence-associated antigens of Shigella flexneri. Mol. Microbiol. 3:627-635[CrossRef][Medline]. |
| 3. | Atlung, T., and H. Ingmer. 1997. H-NS: a modulator of environmentally regulated gene expression. Mol. Microbiol. 24:7-17[CrossRef][Medline]. |
| 4. |
Barth, M.,
C. Marschall,
A. Muffler,
D. Fischer, and R. Hengge-Aronis.
1995.
Role for the histone-like protein H-NS in growth phase-dependent and osmotic regulation of S and many S-dependent genes in Escherichia coli.
J. Bacteriol.
177:3455-3464 |
| 5. |
Beltrametti, F.,
A. U. Kresse, and C. A. Guzman.
1999.
Transcriptional regulation of the esp genes of enterohemorrhagic Escherichia coli.
J. Bacteriol.
181:3409-3418 |
| 6. | Bertin, P., N. Benhabiles, E. Krin, C. Laurent-Winther, C. Tendeng, E. Turlin, A. Thomas, A. Danchin, and R. Brasseur. 1999. The structural and functional organization of H-NS-like proteins is evolutionarily conserved in gram-negative bacteria. Mol. Microbiol. 31:319-329[CrossRef][Medline]. |
| 7. | Bertin, P., P. Lejeune, C. Laurent-Winther, and A. Danchin. 1990. Mutations in bglY, the structural gene for the DNA-binding protein H1, affect expression of several Escherichia coli genes. Biochimie 72:889-891[Medline]. |
| 8. |
Bertin, P.,
E. Terao,
E. H. Lee,
P. Lejeune,
C. Colson,
A. Danchin, and E. Collatz.
1994.
The H-NS protein is involved in the biogenesis of flagella in Escherichia coli.
J. Bacteriol.
176:5537-5540 |
| 9. |
Buggy, J. J.,
M. W. Sganga, and C. E. Bauer.
1994.
Characterization of a light-responsive trans-activator responsible for differentially controlling reaction center and light-harvesting-1 gene expression in Rhodobacter capsulatus.
J. Bacteriol.
176:6936-6943 |
| 10. |
Bustamente, V. H.,
E. Calva, and J. L. Puente.
1998.
Analysis of cis-acting elements required for bfpA expression in enteropathogenic Escherichia coli.
J. Bacteriol.
180:3013-3016 |
| 11. | Cusick, M. E., and M. Belfort. 1998. Domain structure and RNA annealing activity of the Escherichia coli regulatory protein StpA. Mol. Microbiol. 28:847-857[CrossRef][Medline]. |
| 12. |
Donnenberg, M. S., and J. B. Kaper.
1991.
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector.
Infect. Immun.
59:4310-4317 |
| 13. | Donnenberg, M. S., J. B. Kaper, and B. B. Finlay. 1997. Interactions between enteropathogenic Escherichia coli and host epithelial cells. Trends Microbiol. 5:109-114[CrossRef][Medline]. |
| 14. | Donnenberg, M. S. 1995. Enteropathogenic Escherichia coli, p. 709-726. In M. J. Blaser, P. D. Smith, J. I. Ravdin, H. B. Greenberg, and R. L. Guerrant (ed.), Infections of the gastrointestinal tract. Raven Press, New York, N.Y. |
| 15. | Dorman, C. J., and M. E. Porter. 1998. The Shigella virulence gene regulatory cascade: a paradigm of bacterial gene control mechanisms. Mol. Microbiol. 29:677-684[CrossRef][Medline]. |
| 16. | Dorman, C. J., J. C. Hinton, and A. Free. 1999. Domain organization and oligomerization among H-NS-like nucleoid-associated proteins in bacteria. Trends Microbiol. 7:124-128[CrossRef][Medline]. |
| 17. | Ebel, F., T. Podzadel, M. Rohde, A. U. Kresse, S. Krämer, C. Deibel, C. A. Guzman, and T. Chakraborty. 1998. Initial binding of shiga toxin-producing Escherichia coli to host cells and subsequent induction of actin rearrangements depend on filamentous EspA-containing surface appendages. Mol. Microbiol. 30:147-161[CrossRef][Medline]. |
| 18. | Elliott, S. J., L. A. Wainwright, T. K. McDaniel, K. G. Jarvis, Y. Deng, L. Lai, B. P. McNamara, M. S. Donnenberg, and J. B. Kaper. 1998. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol. Microbiol. 28:1-4[CrossRef][Medline]. |
| 19. | Gómez-Duarte, O. G., and J. B. Kaper. 1995. A plasmid-encoded regulatory region activates chromosomal eaeA expression in enteropathogenic Escherichia coli. Infect. Immun. 63:1767-1776[Abstract]. |
| 20. |
Gottesman, S.,
E. Halpern, and P. Trisler.
1981.
Role of sulA and sulB in filamentation by lon mutants of Escherichia coli K-12.
J. Bacteriol.
148:265-273 |
| 21. | Goyard, S., and P. Bertin. 1997. Characterization of BpH3, an H-NS like protein in Bordetella pertussis. Mol. Microbiol. 24:815-823[CrossRef][Medline]. |
| 22. | Higgins, D. G., and P. M. Sharp. 1988. CLUSTAL: a package for performing multiple sequence alignments on a microcomputer. Gene 73:237-244[CrossRef][Medline]. |
| 23. | Jarvis, K. G., and J. B. Kaper. 1996. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infect. Immun. 64:4826-4829[Abstract]. |
| 24. |
Jarvis, K. G.,
J. A. Giron,
A. E. Jerse,
T. K. McDaniel,
M. S. Donnenberg, and J. B. Kaper.
1995.
Enteropathogenic Escherichia coli contains a specialized secretion system necessary for the export of proteins involved in attaching and effacing lesion formation.
Proc. Natl. Acad. Sci. USA
92:7996-8000 |
| 25. |
Jerse, A. E.,
J. Yu,
B. D. Tall, and J. B. Kaper.
1990.
A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.
Proc. Natl. Acad. Sci. USA
87:7839-7843 |
| 26. |
Karmali, M. A.
1989.
Infection by verocytotoxin-producing Escherichia coli.
Clin. Microbiol. Rev.
2:15-38 |
| 27. |
Kenny, B., and B. B. Finlay.
1995.
Protein secretion by enteropathogenic Escherichia coli is essential for transducing signals to epithelial cells.
Proc. Natl. Acad. Sci. USA
92:7991-7995 |
| 28. | Kenny, B., R. DeVinney, M. Stein, D. J. Reinscheid, E. A. Frey, and B. B. Finlay. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520[CrossRef][Medline]. |
| 29. | Kenny, B., L.-C. Lai, B. B. Finlay, and M. S. Donnenberg. 1996. EspA, a protein secreted by enteropathogenic Escherichia coli, is required to induce signals in epithelial cells. Mol. Microbiol. 20:313-323[CrossRef][Medline]. |
| 30. | Knutton, S., J. Adu-Bobie, C. Bain, A. D. Phillips, G. Dougan, and G. Frankel. 1997. Down regulation of intimin expression during attaching and effacing enteropathogenic Escherichia coli adhesion. Infect. Immun. 65:1644-1652[Abstract]. |
| 31. |
Knutton, S.,
T. Baldwin,
P. H. Williams, and A. S. McNeish.
1989.
Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.
Infect. Immun.
57:1290-1298 |
| 32. | Knutton, S., I. Rosenshine, M. J. Pallen, I. Nisan, B. C. Neves, C. Bain, et al. 1998. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 17:2166-2176[CrossRef][Medline]. |
| 33. |
Kresse, A. U.,
M. Rohde, and C. A. Guzman.
1999.
The EspD protein of enterohemorrhagic Escherichia coli is required for the formation of bacterial surface appendages and is incorporated in the cytoplasmic membranes of target cells.
Infect. Immun.
67:4834-4842 |
| 34. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[CrossRef][Medline]. |
| 35. |
Lucht, J. M.,
P. Dersch,
B. Kempf, and R. Bremer.
1994.
Interactions of the nucleoid-associated DNA binding protein H-NS with the regulatory region of the osmotically controlled proU operon of Escherichia coli.
J. Biol. Chem.
269:6578-6586 |
| 36. | McDaniel, T. K., and J. B. Kaper. 1997. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol. Microbiol. 23:399-407[CrossRef][Medline]. |
| 37. | McKee, M. L., A. R. Melton-Celsa, R. A. Moxley, D. H. Francis, and A. D. O'Brien. 1995. Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect. Immun. 63:3739-3744[Abstract]. |
| 38. | Mellies, J. L., S. J. Elliott, V. Sperandio, M. S. Donnenberg, and J. B. Kaper. 1999. The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol. Microbiol. 33:296-306[CrossRef][Medline]. |
| 39. | Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratories, Cold Spring Harbor, N.Y. |
| 40. |
Nataro, J. P., and J. B. Kaper.
1998.
Diarrheagenic Escherichia coli.
Clin. Microbiol. Rev.
11:142-201 |
| 41. |
Paton, A. W.,
P. A. Manning,
M. C. Woodrow, and J. C. Paton.
1998.
Translocated intimin receptors (Tir) of Shiga-toxigenic Escherichia coli isolates belonging to serogroups O26, O111, and O157 react with sera from patients with hemolytic-uremic syndrome and exhibit marked sequence heterogeneity.
Infect. Immun.
66:5580-5586 |
| 42. | Paton, A. W., R. Ratcliff, R. M. Doyle, J. Seymour-Murray, D. Davos, J. A. Lanser, and J. C. Paton. 1996. Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli. J. Clin. Microbiol. 34:1622-1627[Abstract]. |
| 43. | Paton, A. W., E. Voss, P. A. Manning, and J. C. Paton. 1997. Shiga toxin-producing Escherichia coli isolates from cases of human disease show enhanced adherence to intestinal epithelial (Henle 407) cells. Infect. Immun. 65:3799-3805[Abstract]. |
| 44. |
Paton, A. W.,
M. C. Woodrow,
R. M. Doyle,
J. A. Lanser, and J. C. Paton.
1999.
Molecular characterization of a Shiga-toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome.
J. Clin. Microbiol.
37:3357-3361 |
| 45. |
Paton, J. C., and A. W. Paton.
1998.
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections.
Clin. Microbiol. Rev.
11:450-479 |
| 46. |
Perna, N. T.,
G. F. Mayhew,
G. Posfai,
S. Elliott,
M. S. Donnenberg,
J. B. Kaper, and F. R. Blattner.
1998.
Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7.
Infect. Immun.
66:3810-3817 |
| 47. | Riley, L. W., R. S. Remis, S. D. Helgerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T. Hargrett, P. A. Blake, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685[Abstract]. |
| 48. | Rimsky, S., and A. Spassky. 1990. Sequence determinants for H1 binding on Escherichia coli lac and gal promoters. Biochemistry 29:3765-3771[CrossRef][Medline]. |
| 49. | Shindo, H., T. Iwaki, R. Ieda, H. Kurumizaka, C. Ueguchi, T. Mizuno, S. Morikawa, H. Nakamura, and H. Kuboniwa. 1995. Solution structure of the DNA binding domain of a nucleoid-associated protein, H-NS, from Escherichia coli. FEBS Lett. 360:125-131[CrossRef][Medline]. |
| 50. |
Taylor, K. A.,
C. B. O'Connell,
P. W. Luther, and M. S. Donnenberg.
1998.
The EspB protein of enteropathogenic Escherichia coli is targeted to the cytoplasm of infected HeLa cells.
Infect. Immun.
66:5501-5507 |
| 51. | Tobe, T., G. K. Schoolnik, I. Sohel, V. H. Bustamante, and J. L. Puente. 1996. Cloning and characterization of bfpTVW, genes required for the transcriptional activation of bfpA in enteropathogenic Escherichia coli. Mol. Microbiol. 21:963-975[CrossRef][Medline]. |
| 52. |
Tobe, T.,
M. Yoshikawa,
T. Mizuno, and C. Sasakawa.
1993.
Transcriptional control of the invasion regulatory gene virB of Shigella flexneri: activation by VirF and repression by H-NS.
J. Bacteriol.
175:6142-6149 |
| 53. | Ueguchi, C., and T. Mizuno. 1993. The Escherichia coli nucleoid protein H-NS functions directly as a transcriptional repressor. EMBO J. 12:1039-1046[Medline]. |
| 54. | Ueguchi, C., C. Seto, T. Suzuki, and T. Mizuno. 1997. Clarification of the oligomerization domain and its functional significance for the Escherichia coli nucleoid protein H-NS. J. Mol. Biol. 274:145-151[CrossRef][Medline]. |
| 55. |
Voss, E.,
A. W. Paton,
P. A. Manning, and J. C. Paton.
1998.
Molecular analysis of Shiga toxigenic Escherichia coli O111:H proteins which react with sera from patients with hemolytic-uremic syndrome.
Infect. Immun.
66:1467-1472 |
| 56. | Wieler, L. H., E. Vieler, C. Erpenstein, T. Schlapp, H. Steinruck, R. Bauerfeind, A. Byomi, and G. Baljer. 1996. Shiga toxin-producing Escherichia coli strains from bovines: association of adhesion with carriage of eae and other genes. J. Clin. Microbiol. 34:2980-2984[Abstract]. |
| 57. |
Williams, R. M.,
S. Rimsky, and H. Buc.
1996.
Probing the structure, function, and interactions of the Escherichia coli H-NS and StpA proteins using dominant negative derivatives.
J. Bacteriol.
178:4335-4343 |
| 58. | Yamada, H., T. Yoshida, K.-I. Tanaka, C. Sasakawa, and T. Mizuno. 1991. Molecular analysis of the Escherichia coli hns gene encoding a DNA-binding protein, which preferentially recognizes curved DNA sequences. Mol. Gen. Genet. 230:332-336[CrossRef][Medline]. |
| 59. |
Zhang, A., and M. Belfort.
1992.
Nucleotide sequence of a newly-identified Escherichia coli gene, stpA, encoding an H-NS-like protein.
Nucleic Acids Res.
20:6735 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»